CONGRESS|#EHA 2021|Afsaneh M. Shariatpanahi, OS/PFS risk score (Inflammation score) based on expression of selective genes, achieved the best outcome & superior performance compared to ISS& R-ISS. #mmsm, #myeloma, Terry Fox Laboratory. pic.twitter.com/7nJrBW7sVc
— Multiple Myeloma Hub (@MM_Hub) June 11, 2021